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Isosteric replacement is a widely used approach within medicinal chemistry for improving properties of a lead 
compound such as bioavailability, selectivity, and potency. A number of bioisosteric relationships have been 
established for a number of functional groups including the carboxylic acid. Heterocyles such as tetrazole, 3-
hydroxyisoxazole, 3-hydroxyisothiazole, 3-hydroxy-1,2,5-thiadiazole, 3-cyclobutene-1,2-dione and the 1,2,5-
oxadiazole system have been successfully applied as carboxylic acid bioisosteres. Medicinal chemistry 
programmes have provided an extensive variety of bioisosteric replacements for the carboxylic acid in 
GABA, the major inhibitory neurotransmitter in the mammalian central nervous system. The 3-
hydroxypyrazole ring system has previously been shown to be a bioisostere of the carboxylic acid of GABA 
within the GABAa receptor system. In this study, we introduce the bicyclic hydroxypyrazolo[1,5-a]pyridine 
scaffold (see scaffold 1) as the main backbone of potential ligands for the orthosteric site in the 
GABAa receptor. Apart from mimicking the acidic properties of the carboxylic acid group in GABA and the 3-
hydroxyisoxazole in the GABAa agonists, THIP and muscimol, the conformational locked 
hydroxypyrazolo[1,5-a]pyridine moiety offer additional positions for introducing substituents in fixed 
directions. Taking advantage of this option, we have investigated the effect of introducing the amino 
containing substituents in different positions of the scaffold (1) and of the corresponding piperidine scaffold 
(2), thus enabling investigation of the requirement for the mutual position of the functional groups and 
exposing access to cavities/channels associated to the orthosteric binding site, reaching out for subtype-
selectivity. 
 
A series of hydroxypyrazolo[1,5-a]pyridine (1) and hydroxypyrazolo[1,5-a]piperidine (2) derivatives were 
synthesized and pharmacologically characterized in a [
3
H]-muscimol displacement assay at native 
GABAa receptors and electrophysiological assays at relevant GABAa receptor subtypes. The synthesis and 
pharmacological properties are reported and discussed in terms of the structural knowledge available for the 
GABAa receptor. 
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